Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01291836Completed

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

Role: collaborator

NCT03194880Completed

Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand

Role: collaborator

NCT04107220Not ApplicableUnknown

Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure

Role: collaborator

NCT01497054Completed

Do Elevated BNP Levels Predict Hemodynamically Significant PDAs

Role: collaborator

All 4 trials loaded